Gabrail Cancer Center Research

Gabrail Cancer Center Research is a premier clinical research site and community oncology practice headquartered in Canton, Ohio. Established in 1990 by Dr. Nashat Gabrail, the center has developed a national reputation for excellence in Phase 1 through Phase 3 clinical trials, particularly in oncology and hematology. The facility is equipped with a dedicated Phase 1 research unit, on-site diagnostic imaging, a high-complexity laboratory, and a retail pharmacy to provide integrated patient care. In recent years, the research division joined the PhaseWell Research network, enhancing its ability to partner with major pharmaceutical sponsors and CROs. The center has participated in over 350 clinical trials, contributing to the development of numerous FDA-approved therapies.